nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A4—nephron—nephrolithiasis	0.0776	0.179	CbGeAlD
Dapagliflozin—SLC5A4—urine—nephrolithiasis	0.0622	0.143	CbGeAlD
Dapagliflozin—SLC5A2—nephron—nephrolithiasis	0.0588	0.135	CbGeAlD
Dapagliflozin—SLC5A2—urine—nephrolithiasis	0.0471	0.109	CbGeAlD
Dapagliflozin—SLC5A4—nephron tubule—nephrolithiasis	0.0167	0.0386	CbGeAlD
Dapagliflozin—SLC5A4—renal system—nephrolithiasis	0.0152	0.0351	CbGeAlD
Dapagliflozin—SLC5A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0147	0.0306	CbGpPWpGaD
Dapagliflozin—SLC5A4—kidney—nephrolithiasis	0.0147	0.0339	CbGeAlD
Dapagliflozin—SLC5A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0137	0.0285	CbGpPWpGaD
Dapagliflozin—SLC5A11—cortex of kidney—nephrolithiasis	0.013	0.03	CbGeAlD
Dapagliflozin—SLC5A2—nephron tubule—nephrolithiasis	0.0127	0.0292	CbGeAlD
Dapagliflozin—SLC5A2—renal system—nephrolithiasis	0.0115	0.0266	CbGeAlD
Dapagliflozin—SLC5A2—kidney—nephrolithiasis	0.0112	0.0257	CbGeAlD
Dapagliflozin—SLC5A2—cortex of kidney—nephrolithiasis	0.0109	0.025	CbGeAlD
Dapagliflozin—SLC5A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0107	0.0223	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00999	0.0208	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—SLC2A9—nephrolithiasis	0.00988	0.0205	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00966	0.0201	CbGpPWpGaD
Dapagliflozin—SLC5A1—nephron tubule—nephrolithiasis	0.00962	0.0222	CbGeAlD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00883	0.0184	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00883	0.0184	CbGpPWpGaD
Dapagliflozin—SLC5A1—renal system—nephrolithiasis	0.00874	0.0201	CbGeAlD
Dapagliflozin—SLC5A1—kidney—nephrolithiasis	0.00845	0.0195	CbGeAlD
Dapagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00815	0.0169	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00815	0.0169	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00757	0.0157	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00757	0.0157	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.0072	0.015	CbGpPWpGaD
Dapagliflozin—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00716	0.0846	CcSEcCtD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00705	0.0146	CbGpPWpGaD
Dapagliflozin—CYP1A2—urine—nephrolithiasis	0.00682	0.0157	CbGeAlD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00669	0.0139	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00669	0.0139	CbGpPWpGaD
Dapagliflozin—CYP2C9—urine—nephrolithiasis	0.00648	0.0149	CbGeAlD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00644	0.0134	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00644	0.0134	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—SLC26A1—nephrolithiasis	0.00632	0.0131	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00622	0.0129	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00622	0.0129	CbGpPWpGaD
Dapagliflozin—SLC5A11—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00555	0.0115	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00551	0.0114	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00551	0.0114	CbGpPWpGaD
Dapagliflozin—UGT1A9—renal system—nephrolithiasis	0.0055	0.0127	CbGeAlD
Dapagliflozin—SLC5A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00546	0.0113	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00546	0.0113	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00534	0.0111	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00534	0.0111	CbGpPWpGaD
Dapagliflozin—UGT1A9—kidney—nephrolithiasis	0.00532	0.0123	CbGeAlD
Dapagliflozin—CYP3A4—urine—nephrolithiasis	0.00494	0.0114	CbGeAlD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00491	0.0102	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00488	0.0101	CbGpPWpGaD
Dapagliflozin—CYP2D6—urine—nephrolithiasis	0.00486	0.0112	CbGeAlD
Dapagliflozin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00475	0.0561	CcSEcCtD
Dapagliflozin—SLC5A4—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00455	0.00946	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00454	0.00943	CbGpPWpGaD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00454	0.00943	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00449	0.00933	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00449	0.00933	CbGpPWpGaD
Dapagliflozin—UGT2B7—renal system—nephrolithiasis	0.00444	0.0102	CbGeAlD
Dapagliflozin—UGT2B7—kidney—nephrolithiasis	0.00429	0.00988	CbGeAlD
Dapagliflozin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00416	0.0491	CcSEcCtD
Dapagliflozin—SLC5A4—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00405	0.00841	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00402	0.00835	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00402	0.00835	CbGpPWpGaD
Dapagliflozin—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00398	0.0471	CcSEcCtD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0037	0.00769	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0037	0.00769	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0037	0.00769	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0037	0.00769	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—SLC26A1—nephrolithiasis	0.0037	0.00768	CbGpPWpGaD
Dapagliflozin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00368	0.0434	CcSEcCtD
Dapagliflozin—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00364	0.043	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00358	0.00744	CbGpPWpGaD
Dapagliflozin—SLC5A1—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00345	0.00717	CbGpPWpGaD
Dapagliflozin—SLC5A2—Carbohydrate metabolism—SLC26A1—nephrolithiasis	0.00345	0.00717	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00344	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00344	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00344	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00344	0.00715	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0034	0.00707	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0034	0.00707	CbGpPWpGaD
Dapagliflozin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00336	0.0397	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00327	0.0068	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00327	0.0068	CbGpPWpGaD
Dapagliflozin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00321	0.0379	CcSEcCtD
Dapagliflozin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0032	0.0378	CcSEcCtD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00316	0.00657	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00316	0.00657	CbGpPWpGaD
Dapagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00307	0.00637	CbGpPWpGaD
Dapagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00307	0.00637	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00304	0.00633	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00304	0.00633	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00304	0.00633	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00304	0.00633	CbGpPWpGaD
Dapagliflozin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.003	0.0354	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00292	0.0345	CcSEcCtD
Dapagliflozin—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00288	0.00598	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00282	0.00586	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00282	0.00586	CbGpPWpGaD
Dapagliflozin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00277	0.0327	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00271	0.00564	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00271	0.00564	CbGpPWpGaD
Dapagliflozin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00269	0.0318	CcSEcCtD
Dapagliflozin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00259	0.0305	CcSEcCtD
Dapagliflozin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00255	0.0302	CcSEcCtD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00248	0.00516	CbGpPWpGaD
Dapagliflozin—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00243	0.0287	CcSEcCtD
Dapagliflozin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0286	CcSEcCtD
Dapagliflozin—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0285	CcSEcCtD
Dapagliflozin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0024	0.0283	CcSEcCtD
Dapagliflozin—UGT1A9—Phase II conjugation—SLC26A1—nephrolithiasis	0.00234	0.00486	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00231	0.00479	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00231	0.00479	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00225	0.00468	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00206	0.00427	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00206	0.00427	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00192	0.00399	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00188	0.00391	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00188	0.00391	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00188	0.00391	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00188	0.00391	CbGpPWpGaD
Dapagliflozin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00186	0.022	CcSEcCtD
Dapagliflozin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00176	0.0208	CcSEcCtD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00175	0.00363	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00175	0.00363	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00175	0.00363	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00175	0.00363	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00168	0.0035	CbGpPWpGaD
Dapagliflozin—CYP1A2—renal system—nephrolithiasis	0.00167	0.00385	CbGeAlD
Dapagliflozin—CYP1A1—renal system—nephrolithiasis	0.00165	0.00379	CbGeAlD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00164	0.00342	CbGpPWpGaD
Dapagliflozin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0191	CcSEcCtD
Dapagliflozin—CYP1A1—kidney—nephrolithiasis	0.00159	0.00367	CbGeAlD
Dapagliflozin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00157	0.0186	CcSEcCtD
Dapagliflozin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00157	0.0186	CcSEcCtD
Dapagliflozin—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00156	0.00324	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00156	0.00324	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00156	0.00324	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00156	0.00324	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00156	0.00324	CbGpPWpGaD
Dapagliflozin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00152	0.018	CcSEcCtD
Dapagliflozin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0174	CcSEcCtD
Dapagliflozin—SLC5A4—Metabolism—GRHPR—nephrolithiasis	0.00143	0.00296	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00137	0.00284	CbGpPWpGaD
Dapagliflozin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0159	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—SLC26A1—nephrolithiasis	0.00129	0.00268	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—AGXT—nephrolithiasis	0.00127	0.00264	CbGpPWpGaD
Dapagliflozin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00125	0.0148	CcSEcCtD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00125	0.00259	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00125	0.00259	CbGpPWpGaD
Dapagliflozin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00124	0.0147	CcSEcCtD
Dapagliflozin—CYP3A4—renal system—nephrolithiasis	0.00121	0.00278	CbGeAlD
Dapagliflozin—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.0012	0.0025	CbGpPWpGaD
Dapagliflozin—CYP2D6—renal system—nephrolithiasis	0.00119	0.00274	CbGeAlD
Dapagliflozin—CYP3A4—kidney—nephrolithiasis	0.00117	0.00269	CbGeAlD
Dapagliflozin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0137	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—ATP6V0A4—nephrolithiasis	0.00115	0.00239	CbGpPWpGaD
Dapagliflozin—CYP2D6—kidney—nephrolithiasis	0.00115	0.00265	CbGeAlD
Dapagliflozin—SLC5A4—Metabolism—SLC26A1—nephrolithiasis	0.00108	0.00225	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—APRT—nephrolithiasis	0.00108	0.00225	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GRHPR—nephrolithiasis	0.00108	0.00225	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GRHPR—nephrolithiasis	0.00108	0.00225	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00105	0.00219	CbGpPWpGaD
Dapagliflozin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00104	0.0123	CcSEcCtD
Dapagliflozin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000991	0.0117	CcSEcCtD
Dapagliflozin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00099	0.0117	CcSEcCtD
Dapagliflozin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000985	0.0116	CcSEcCtD
Dapagliflozin—SLC5A1—Disease—SLC26A1—nephrolithiasis	0.000978	0.00203	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—SLC26A1—nephrolithiasis	0.000978	0.00203	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AGXT—nephrolithiasis	0.000963	0.002	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AGXT—nephrolithiasis	0.000963	0.002	CbGpPWpGaD
Dapagliflozin—ABCB1—nephron tubule—nephrolithiasis	0.000941	0.00217	CbGeAlD
Dapagliflozin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000934	0.011	CcSEcCtD
Dapagliflozin—SLC5A1—Disease—ATP6V0A4—nephrolithiasis	0.000872	0.00181	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—ATP6V0A4—nephrolithiasis	0.000872	0.00181	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000857	0.00178	CbGpPWpGaD
Dapagliflozin—ABCB1—renal system—nephrolithiasis	0.000855	0.00197	CbGeAlD
Dapagliflozin—UGT2B4—Metabolism—GRHPR—nephrolithiasis	0.000834	0.00173	CbGpPWpGaD
Dapagliflozin—ABCB1—kidney—nephrolithiasis	0.000827	0.00191	CbGeAlD
Dapagliflozin—SLC5A2—Metabolism—APRT—nephrolithiasis	0.000819	0.0017	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—APRT—nephrolithiasis	0.000819	0.0017	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—SLC26A1—nephrolithiasis	0.000819	0.0017	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—SLC26A1—nephrolithiasis	0.000819	0.0017	CbGpPWpGaD
Dapagliflozin—ABCB1—cortex of kidney—nephrolithiasis	0.000805	0.00186	CbGeAlD
Dapagliflozin—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000786	0.00163	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—AQP1—nephrolithiasis	0.00077	0.0016	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AGXT—nephrolithiasis	0.000744	0.00155	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CHRM3—nephrolithiasis	0.000696	0.00145	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—APRT—nephrolithiasis	0.000632	0.00131	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—SLC26A1—nephrolithiasis	0.000632	0.00131	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000592	0.00123	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000586	0.00122	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AQP1—nephrolithiasis	0.000584	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AQP1—nephrolithiasis	0.000584	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CHRM3—nephrolithiasis	0.000528	0.0011	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CHRM3—nephrolithiasis	0.000528	0.0011	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000501	0.00104	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AQP1—nephrolithiasis	0.000451	0.000936	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CHRM3—nephrolithiasis	0.000407	0.000847	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000399	0.000829	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000399	0.000829	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000387	0.000804	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.00038	0.00079	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000356	0.000739	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000339	0.000704	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000325	0.000676	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000325	0.000676	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.000309	0.000642	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000288	0.000598	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000288	0.000598	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000275	0.000572	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000247	0.000512	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000247	0.000512	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000238	0.000495	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000234	0.000486	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000234	0.000486	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000229	0.000476	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000229	0.000476	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000212	0.000441	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000205	0.000426	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000204	0.000425	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000204	0.000425	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.000186	0.000386	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.00018	0.000375	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—APRT—nephrolithiasis	0.00018	0.000375	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000177	0.000369	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000167	0.000347	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000163	0.000339	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000158	0.000328	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.000151	0.000313	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000142	0.000294	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000134	0.000279	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000134	0.000279	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000133	0.000277	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000132	0.000275	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000129	0.000267	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000126	0.000262	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000119	0.000247	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000118	0.000245	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.000116	0.000242	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000113	0.000235	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000107	0.000223	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—APRT—nephrolithiasis	0.000107	0.000223	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.00021	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000101	0.00021	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000101	0.000209	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—APRT—nephrolithiasis	0.0001	0.000208	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.0001	0.000208	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AQP1—nephrolithiasis	9.58e-05	0.000199	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	8.73e-05	0.000181	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CHRM3—nephrolithiasis	8.66e-05	0.00018	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	8.57e-05	0.000178	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—APRT—nephrolithiasis	8.57e-05	0.000178	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AGXT—nephrolithiasis	7.78e-05	0.000162	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AQP1—nephrolithiasis	7.65e-05	0.000159	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AQP1—nephrolithiasis	7.21e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AQP1—nephrolithiasis	7.15e-05	0.000148	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CHRM3—nephrolithiasis	6.92e-05	0.000144	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—APRT—nephrolithiasis	6.61e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	6.61e-05	0.000137	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CHRM3—nephrolithiasis	6.52e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CHRM3—nephrolithiasis	6.46e-05	0.000134	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AQP1—nephrolithiasis	6.11e-05	0.000127	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CHRM3—nephrolithiasis	5.52e-05	0.000115	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.71e-05	9.79e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	4.26e-05	8.86e-05	CbGpPWpGaD
